NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer. These proteins are implicated in epidermal squamous cell carcinoma in mice, however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours, blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma. Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer, it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon cotransfection with the human TERT gene, defined sets of oncogenes, specifically activated H-RAS, SV40 large T antigen and SV40 small t antigen, resulted in the efficient malignant transformation of human fibroblasts (96).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [96]
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Cutaneous Squamous-Cell Carcinoma
Alam, M., & Ratner, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441306 · Cited by 1,305
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098 · cited 1×
“jpg" NDATA ITEM> ]> The nuclear factor NF-κB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cance”
BackgroundHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 1×
“Ectopic subcutaneous tumour formation in mice often requires administration of matrigel or fibroblast-derived matri”
BackgroundBlocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831 · cited 1×
“Because therapeutics inhibiting Ras and NF-κB pathways are being developed to treat human cance”
Background
Cited by
Items 101–200 of 540
RETRACTED ARTICLE: EET signaling in cancer
Panigrahy, D., Greene, E. R., Pozzi, A., Wang, D. W., & Zeldin, D. C. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9315-y · Cited by 140
RetractedWyke, S. M., & Tisdale, M. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602402 · Cited by 130
“Thus, while in most cell types NF-kB seems to promote cell proliferation and protect against apoptosis, in skin, it appears to oppose proliferation (Dajee et al, 2003).”
BackgroundTargeting integrin β4 for cancer and anti-angiogenic therapy
Giancotti, F. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.08.004 · Cited by 143
Cytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer
Schottelius, A. J. G., & Dinter, H. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_3 · Cited by 146
Siegle, J., Basin, A., Sastre-Perona, A., Yonekubo, Y., Brown, J. A., Sennett, R., Rendl, M., Tsirigos, A., Carucci, J. A., & Schöber, M. (2014) · Nature Communications · doi:10.1038/ncomms5511 · Cited by 136
Horn, E. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh003 · Cited by 126
“However, inhibition of NFkB strongly promotes Ha-Ras tumorigenesis in human keratinocytes ( 40 ).”
BackgroundNF-κB: a new player in angiostatic therapy
Tabruyn, S. P., & Griffioen, A. W. (2008) · Angiogenesis · doi:10.1007/s10456-008-9094-4 · Cited by 127
“This observation could be explained by the fact that in normal human epidermal cells, NF-jB activation induces cell cycle arrest [8].”
BackgroundIRF6 is a mediator of Notch pro‐differentiation and tumour suppressive function in keratinocytes
Restivo, G., Nguyen, B.-C., Dziunycz, P., Ristorcelli, E., Ryan, R. J. H., Yalcin-Ozuysal, Ö., Piazza, M., Radtke, F., Dixon, M. J., Hofbauer, G. F. L., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.325 · Cited by 132
“The LZRS-H-rasV12 (Dajee et al, 2003) retrovirus was provided by Dr P Khavari (Stanford University).”
Methodauf dem Keller, U., Huber, M., Beyer, T. A., Kümin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D. A., Johnson, J. A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3773-3784.2006 · Cited by 123
“Blockage of the NF-B signaling pathway with concomitant up-regulation of Cdk4 and enhanced JNK activity has been implicated in higher susceptibility to skin carcinogenesis ( 13 , 38, 57, 58).”
BackgroundNenci, A., Huth, M., Funteh, A., Schmidt-Supprian, M., Bloch, W., Metzger, D., Chambon, P., Rajewsky, K., Krieg, T., Haase, I., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi470 · Cited by 115
“Furthermore, Dajee et al. ( 13 ) showed that inhibition of NF-kB in combination with expression of oncogenic Ras in human keratinocytes transplanted on the skin of severe combined immunodeficiency (SCID) mice caused the development of invasive tumors resembling squamous cell carcinoma.”
BackgroundLinks between α-catenin, NF-κB, and squamous cell carcinoma in skin
Kobielak, A., & Fuchs, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510422103 · Cited by 125
NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004) · Genes & Development · doi:10.1101/gad.1160904 · Cited by 124
Self-citationLu, S., Simin, K. J., Khan, A. A., & Mercurio, A. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4116 · Cited by 139
α3β1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway
Manohar, A., Shome, S. G., Lamar, J., Stirling, L., Iyer, V., Pumiglia, K., & DiPersio, C. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01277 · Cited by 118
“…high levels in many invasive carcinomas, suggesting possible roles for these adhesion proteins in promoting tumor cell invasion and survival, as well (Dajee et al., 2003; Felding-Habermann, 2003; Bartolazzi et al., 1994; Natali et al., 1993; Patriarca et al., 1998; Lohi et al., 2000; Pyke et…”
BackgroundThe Met pathway: master switch and drug target in cancer progression
Mazzone, M., & Comoglio, P. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-5947rev · Cited by 124
Regamey, A., Hohl, D., Liu, J. W., Roger, T., Kogerman, P., Toftgård, R., & Huber, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031187 · Cited by 117
“Furthermore, coexpression of an oncogenic Ras mutant and the mutant I B cooperated to form highly invasive squamous cell carcinomas in human epidermal keratinocyte grafts (25).”
BackgroundRal GTPases: corrupting the exocyst in cancer cells
Camonis, J., & White, M. A. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.002 · Cited by 133
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation
Zhuang, Z., Ju, H.-Q., Aguilar, M., Gocho, T., Li, H., Iida, T., Lee, H., Fan, X., Zhou, H., Ling, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3382 · Cited by 113
IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis
Cataisson, C., Salcedo, R., Hakim, S., Moffitt, B. A., Wright, L., Yi, M., Stephens, R., Dai, R.-M., Lyakh, L., Schenten, D., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20101355 · Cited by 113
“Activation of RAS through epigenetic regulation is even more frequent in skin tumors (Dajee et al., 2003; Khavari, 2006).”
BackgroundCan NF-κB be a target for novel and efficient anti-cancer agents?
Olivier, S., Robe, P. A. J. T., & Bours, V. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.023 · Cited by 129
Lind, M. H., Rozell, B., Wallin, R. P. A., van Hogerlinden, M., Ljunggren, H.-G., Toftgård, R., & Sur, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307106101 · Cited by 113
Tumor-host interactions: the role of inflammation
Bitoux, M. L., & Stamenkovic, I. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0527-3 · Cited by 129
“It should be borne in mind that potential duality of the inXammatory response to cancer can be regulated by the tissue type, as suggested by a skin tumor model where overexpression of NF- B was observed to inhibit invasive epidermal carcinoma (Dajee et al. 2003).”
PARP1 Inhibitors: Antitumor Drug Design
Malyuchenko, N. V., Kotova, E. Y., Kulaeva, O. I., Kirpichnikov, M. P., & Studitskiy, V. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-3-27-37 · Cited by 109
Involvement of Rel/Nuclear Factor-κB Transcription Factors in Keratinocyte Senescence
Bernard, D., Gosselin, K., Monte, D., Vercamer, C., Bouali, F., Pourtier, A., Vandenbunder, B., & Abbadie, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0005 · Cited by 106
“Similarly, human reconstituted skin implanted in mouse becomes hyperplastic when it overexpresses I B or develops squamous cell carcinoma when it coexpresses I B and Ras (90).”
BackgroundWang, C., Lisanti, M. P., & Liao, D. J. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14449 · Cited by 109
Inflammation and Cancer: Is the Link as Simple as We Think?
Nickoloff, B. J., Ben-Neriah, Y., & Pikarsky, E. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23724.x · Cited by 110
“Moreover, in a skin cancer mouse model, NF-κB was shown to inhibit tumor formation”
BackgroundNF-κB inhibition: A double-edged sword in cancer?
Pikarsky, E., & Ben‐Neriah, Y. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.011 · Cited by 110
Vandermark, E. R., Deluca, K. A., Gardner, C. R., Marker, D. F., Schreiner, C. N., Strickland, D. A., Wilton, K. M., Mondal, S., & Woodworth, C. D. (2012) · Virology · doi:10.1016/j.virol.2011.12.023 · Cited by 106
“Furthermore, immortalization by HPV-16 decreased expression of several β-defensins that are NF-kB-inducible cationic peptides that contribute to innate immunity (Diamond et al., 2008).”
Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
Hopewell, E. L., Zhao, W., Fulp, W. J., Bronk, C. C., Lopez, A. S., Massengill, M., Antonia, S., Celis, E., Haura, E. B., Enkemann, S. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67250 · Cited by 103
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P., Wolvetang, E., Ghysdael, J., Rowe, M., & Hara, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302085 · Cited by 104
“Moreover, a recent report demonstrated that inhibition of NF- B signaling override Ras-induced senescence (Dajee et al., 2003).”
BackgroundNF-κB role on tumor proliferation, migration, invasion and immune escape
Khan, A., Zhang, Y., Ma, N., Shi, J., & Hou, Y. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00811-6 · Cited by 115
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
Li, J., Wang, K., Chen, X., Meng, H., Song, M., Wang, Y., Xu, X., & Bai, Y. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-4 · Cited by 103
“NF-kB had been reported to induce G1 cell cycle arrest in human epithelial cells through increasing of p21 or suppression of CDK4 [36,37].”
BackgroundRaf-1 Addiction in Ras-Induced Skin Carcinogenesis
Ehrenreiter, K., Kern, F., Velamoor, V., Meissl, K., Galabova‐Kovacs, G., Sibilia, M. C., & Baccarini, M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.008 · Cited by 115
“In the specific case of SCC, the majority of spontaneous human tumors display Ras and ERK activation in the absence of somatic Ras mutations, suggesting that other factors, such as the overexpression of receptor tyrosine kinases, may activate the pathway in tumors (Dajee et al., 2003).”
BackgroundInfluentialPegtel, D. M., Subramanian, A., Sheen, T., Tsai, C.-H. A., Golub, T. R., & Thorley‐Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15430-15442.2005 · Cited by 105
MyD88 and its divergent toll in carcinogenesis
Salcedo, R., Cataisson, C., Hasan, U., Yuspa, S. H., & Trinchieri, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.008 · Cited by 94
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
Yang, J., Splittgerber, R., Yull, F. E., Kantrow, S., Ayers, G. D., Karin, M., & Richmond, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 99
Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice
Vlantis, K., Wullaert, A., Sasaki, Y., Schmidt‐Supprian, M., Rajewsky, K., Roskams, T., & Pasparakis, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45349 · Cited by 101
The α6β4 Integrin Maintains the Survival of Human Breast Carcinoma Cells In vivo
Lipscomb, E. A., Simpson, K. J., Lyle, S. R., Ring, J. E., Dugan, A. S., & Mercurio, A. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2327 · Cited by 100
“Using a model system that involves the retroviral expression of specific genes in primary, human keratinocytes, and the subsequent use of these cells for grafting on immune-deficient mice, Khavari’s group reported that coexpression of oncogenic Ras with molecules that impede Ras-induced growth arrest results in invasi…”
BackgroundInfluentialCDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma
McNeal, A. S., Liu, K., Nakhate, V., Natale, C. A., Duperret, E. K., Capell, B. C., Dentchev, T., Berger, S. L., Herlyn, M., Seykora, J. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0196 · Cited by 123
NF-κB and cancer: a paradigm of Yin-Yang.
Xiao, G., & Fu, J. (2011) · American Journal of Cancer Research · Cited by 128
NF-κB in carcinoma therapy and prevention
Brown, M. S., Cohen, J., Arun, P., Chen, Z., & Waes, C. V. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1109 · Cited by 110
Erk1/2 MAP kinases are required for epidermal G2/M progression
Dumesic, P. A., Scholl, F. A., Barragan, D. I., & Khavari, P. A. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200804038 · Cited by 121
“Moreover, most spontaneous epidermal squamous cell carcinomas, which are marked by characteristics of basal layer cells, including integrin expression and proclivity toward proliferation over differentiation, exhibit Ras induction and MAPK cascade hyperactivity (Dajee et al., 2003).”
BackgroundSelf-citationInflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Dobrovolskaia, M. A., & Kozlov, S. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054629645 · Cited by 110
Tetraspanin protein contributions to cancer
Wang, H.-X., Li, Q., Sharma, C., Knoblich, K., & Hemler, M. E. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390547 · Cited by 98
Microenvironmental influences in melanoma progression
Lee, J. T., & Herlyn, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21204 · Cited by 106
“The advantages of such a model are multifaceted: first, it is possible to investigate the genetic events that are sufficient to transform normal cells (i.e., melanocytes) in the context of human tissue [Lazarov et al., 2002; Dajee et al., 2003].”
BackgroundKligys, K. R., Claiborne, J. N., DeBiase, P. J., Hopkinson, S. B., Wu, Y., Mizuno, K., & Jones, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707041200 · Cited by 97
Transcriptional control of epidermal specification and differentiation
Dai, X., & Segre, J. A. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.002 · Cited by 101
Genetics of skin appendage neoplasms and related syndromes
Lee, D. A., Grossman, M. E., Schneiderman, P., & Celebi, J. T. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.025577 · Cited by 99
El-Abaseri, T. B., Fuhrman, J., Trempus, C. S., Shendrik, I., Tennant, R. W., & Hansen, L. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2204 · Cited by 92
“Further support for the relevance of ras mutations in the pathogenesis of nonmelanoma skin cancer comes from research in which the introduction of an activated ras together with either nuclear factor-nB blockade or the expression of exogenous CDK4 produced squamous cell carcinomas in primary human epidermal cells graf…”
BackgroundIntegrin-Associated CD151 Drives ErbB2-Evoked Mammary Tumor Onset and Metastasis
Deng, X., Li, Q., Hoff, J. J., Novak, M., Yang, H. L., Jin, H., Erfani, S., Sharma, C., Zhou, P., Rabinovitz, I., et al. (2012) · Neoplasia · doi:10.1593/neo.12922 · Cited by 91
“[18] Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich”
BackgroundRelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
Wang, J., Jacob, N. K., Ladner, K. J., Beg, A., Perko, J. D., Tanner, S. M., Liyanarachchi, S., Fishel, R., & Guttridge, D. C. (2009) · EMBO reports · doi:10.1038/embor.2009.197 · Cited by 89
“This idea is in agreement with several studies showing that disruption of NF-kB in vivo can stimulate tumour development (Dajee et al, 2003; Maeda et al, 2005; Luedde et al, 2007).”
ResultReuter, J. A., Ortiz-Urda, S., Kretz, M., Garcia, J., Scholl, F. A., Pasmooij, A. M. G., Cassarino, D., Chang, H. Y., & Khavari, P. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.002 · Cited by 88
Self-citationThe Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer
Yang, G. S., Xiao, X., Rosen, D. G., Cheng, X., Wu, X., Chang, B., Liu, G., Xue, F., Mercado‐Uribe, I., Chiao, P. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3265 · Cited by 93
Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis
Fazio, C., & Ricciardiello, L. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.408 · Cited by 93
Raymond, K., Kreft, M., Janssen, H., Calafat, J., & Sonnenberg, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01689 · Cited by 93
“…contributed to our understanding of their role in the development of tissues and organs, and have provided conclusive evidence that integrins not only mediate adhesive events, but also play an instructive role in the formation of these structures (Danen and Sonnenberg, 2003; Bouvard et al., 2001).”
BackgroundREGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway
Li, L., Dang, Y., Zhang, J., Yan, W., Zhai, W., Chen, H., Li, K., Lu, T., Gao, X. C., Amjad, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7875 · Cited by 88
Self-citationCyfip1 is a putative invasion suppressor in epithelial cancers
Silva, J. M., Ezhkova, E., Silva, J., Heart, S., Castillo, M., Campos, Y., Castro, V., Bonilla, F., Cordon-Cardo, C., Muthuswamy, S. K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.013 · Cited by 87
“To probe the relevance of our findings in an in vivo setting, we took advantage of an orthotopic mouse model that has previously been used to study links between cell adhesion and tumor progression (Dajee et al., 2003; Weinberg et al., 1991).”
Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathway
Deng, J., Xia, W., Miller, S. A., Wen, Y., Wang, H., & Hung, M. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.10169 · Cited by 100
Owens, D. M., Romero, M. R., Gardner, C., & Watt, F. M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00725 · Cited by 87
“Human keratinocytes lacking α6β4 are resistant to the tumourigenic effects of Ras and NF-κB (Dajee et al., 2003).”
BackgroundDai, Y., Lawrence, T. S., & Xu, L. (2009) · PubMed · Cited by 87
Laminin-5 in Epithelial Tumour Invasion
Katayama, M., & Sekiguchi, K. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032359.35698.fe · Cited by 87
“LN-5 and its counter receptor, α6β4 integrin, may be prospectively understood as excellent targets in cancer research, as suggested recently (Dajee et al. 2003, Mercurio 2003).”
BackgroundKelly‐Spratt, K. S., Gurley, K. E., Yasui, Y., & Kemp, C. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020242 · Cited by 94
“Ras induces cell motility, invasiveness (Lazarov et al. 2002; Dajee et al. 2003; Kim et al. 2003), epithelial to mesenchymal transition (Oft et al. 1996; Zondag et al. 2000), angiogenesis (Arbiser et al. 1997; Casanova et al. 2002), and metastasis (Pozzatti et al. 1986; Webb et al. 1998; Oft et al.…”
BackgroundOskarsson, T., Essers, M. A. G., Dubois, N., Offner, S., Dubey, C., Roger, C., Metzger, D., Chambon, P., Hummler, E., Beard, P., et al. (2006) · Genes & Development · doi:10.1101/gad.381206 · Cited by 82
“In contrast, c-Myc is dispensable for maintenance of the adult intestinal mucosa (de Alboran et al. 2001; Trumpp et al. 2001; Wilson et al. 2004; Bettess et al. 2005; Murphy et al. 2005; Wilson and Trumpp 2006; N. Dubois and A. Trumpp, unpubl.).”
BackgroundBisecting GlcNAc Residues on Laminin-332 Down-regulate Galectin-3-dependent Keratinocyte Motility
Kariya, Y., Kawamura, C., Tabei, T., & Gu, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038836 · Cited by 94
Targeting a Tumor-Specific Laminin Domain Critical for Human Carcinogenesis
Tran, M., Rousselle, P., Nokelainen, P., Tallapragada, S., Nguyen, N. T., Fincher, E. F., & Marinkovich, M. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6160 · Cited by 85
“Tumorigenicity assay. Tumorgenicity assay was performed as previously described ( 9 ).”
BackgroundMethodInfluentialSelf-citationWang, J., Ratnam, N. M., Byrd, J. C., & Guttridge, D. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.049 · Cited by 94
“One possibility is that either its tumor suppressor or tumor promoter activity is restricted to one cell type, as seen in keratinocytes (Dajee et al., 2003) or colon cells, respectively (Schwitalla et al., 2013; Shaked et al., 2012).”
BackgroundNon-Angiogenic Functions of VEGF in Breast Cancer
Mercurio, A. M., Lipscomb, E. A., & Bachelder, R. E. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9001-9 · Cited by 88
“In addition, a study using a mouse model of human squamous carcinoma concluded that α6β4 is necessary for tumor formation [57].”
BackgroundKato, K., Shiga, K., Yamaguchi, K., Hata, K., Kobayashi, T., Miyazaki, K., Saijo, S., & Miyagi, T. (2006) · Biochemical Journal · doi:10.1042/bj20050737 · Cited by 81
Integrin Regulation of Epidermal Functions in Wounds
Longmate, W. M., & DiPersio, C. M. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0516 · Cited by 83
Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention
Chang, M. S., Azin, M., & Demehri, S. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-120056 · Cited by 80
miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma
Gastaldi, C., Bertero, T., Xu, N., Bourget, I., Lebrigand, K., Fourré, S., Popa, A., Cardot‐Leccia, N., Meneguzzi, G., Sonkoly, E., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt490 · Cited by 79
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
Li, T., Zhang, Q., Zhang, J., Yang, G. S., Shao, Z., Luo, J., Fan, M., Chen, N., Wu, Z., & Hu, X. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-96 · Cited by 78
“Consistent with our findings, several studies showed that upregulation of NF-κB was associated with cyanide-induced apoptosis [34], thymocyte apoptosis [35], both paclitaxeland doxorubicin-induced apoptosis [36,37], and acted as anti-oncogene [38,39].”
ResultSelf-citationTetraspanin CD151 plays a key role in skin squamous cell carcinoma
Li, Q., Yang, X. H., Xu, F., Sharma, C., Wang, H.-X., Knoblich, K., Rabinovitz, I., Granter, S. R., & Hemler, M. E. (2012) · Oncogene · doi:10.1038/onc.2012.205 · Cited by 82
Tsai, K. Y., & Tsao, H. (2004) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30037 · Cited by 87
Singh, K., Chaturvedi, R., Barry, D. P., Coburn, L. A., Asim, M., Lewis, N. D., Piazuelo, M. B., Washington, M. K., Vitek, M. P., & Wilson, K. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176719 · Cited by 83
Benard, C., Cultrone, A., Michel, C., Rosales, C., Segain, J.-P., Lahaye, M., Galmiche, J.-P., Cherbut, C., & Blottière, H. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008666 · Cited by 76
Okuyama, R., Ogawa, E., Nagoshi, H., Yabuki, M., Kurihara, A., Terui, T., Aiba, S., Obinata, M., Tagami, H., & Ikawa, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210235 · Cited by 80
“As the enhanced expression of integrin a6b4 together with activation of RAS oncogene or inhibition of nuclear factor kappa B (NFkB) pathway will lead to development of invasive epidermal neoplasia (Dajee et al., 2003), we speculate this ability of DNp51B to induce integrin a6b4 is closely linked to its tumourigenic na…”
BackgroundMultifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma
Porcheri, C., Meisel, C. T., & Mitsiadis, T. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061520 · Cited by 79
Kapoor, G. S., Zhan, Y., Johnson, G. R., & O'Rourke, D. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.823-836.2004 · Cited by 73
Emerging Mechanisms of Immunosuppression in Oral Cancers
Jewett, A., Head, C. S., & Cacalano, N. A. (2006) · Journal of Dental Research · doi:10.1177/154405910608501201 · Cited by 83
Thrash, B. R., Menges, C. W., Pierce, R. H., & McCance, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512116200 · Cited by 77
Integrin α6β4 Promotes Migration, Invasion through Tiam1 Upregulation, and Subsequent Rac Activation
Cruz‐Monserrate, Z., & O’Connor, K. L. (2008) · Neoplasia · doi:10.1593/neo.07868 · Cited by 82
Shibata, W., Takaishi, S., Muthupalani, S., Pritchard, D. M., Whary, M. T., Rogers, A. B., Fox, J. G., Betz, K. S., Kaestner, K. H., Karin, M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.054 · Cited by 74
Mek1 Alters Epidermal Growth and Differentiation
Scholl, F. A., Dumesic, P. A., & Khavari, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0017 · Cited by 73
“The finding that the Ras-MAPK cascade is up-regulated in a substantial proportion of human squamous cell carcinomas, even in the absence of primary mutations in RAS genes ( 27 ), additionally supports efforts to explore Mek inhibition in squamous cell carcinoma.”
MethodResultSelf-citationSong, S., Chen, D., Lü, J., Liao, J., Luo, Y., Yang, Z., Fu, X., Fan, X., Wei, Y., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021726 · Cited by 71
“Furthermore, activity of NFkB has been observed in several types of cancers including CRC [21,22], indicating it may play an important role in tumorigenesis [23,24].”
BackgroundSachs, N., Secades, P., van Hulst, L., Kreft, M., Song, J., & Sonnenberg, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204614110 · Cited by 71
A role for IκB kinase 2 in bipolar spindle assembly
Irelan, J. T., Murphy, T. J., DeJesus, P., Teo, H., Xu, D., Gómez-Ferrería, M. A., Zhou, Y., Miraglia, L. J., Rines, D. R., Verma, I. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706493104 · Cited by 70
Cataisson, C., Ohman, R., Patel, G., Pearson, A., Tsien, M. Z., Jay, S., Wright, L. N., Hennings, H., & Yuspa, S. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2490 · Cited by 70
“Activating mutations in ras genes are observed in human SCC (27) and in experimental cutaneous SCC induction in mice (28), and in the absence of mutations, human SCCs frequently show increased Ras activity and MAPK activation (29).”
Pai, P., & Sukumar, S. V. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188450 · Cited by 71
Frelin, C., Imbert, V., Griessinger, E., Loubat, A., Dréano, M., & Peyron, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206963 · Cited by 69
“For instance, in the skin, inhibition of NF-kB cooperates with active ras protein to relieve a proliferation block and induce tumors (Dajee et al., 2003).”
BackgroundMolecular organization of the basement membrane zone
Hashmi, S., & Marinkovich, M. P. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.01.009 · Cited by 75
Self-citationXie, Y., Wu, L., Wang, M., Cheng, A., Yang, Q., Wu, Y., Jia, R., Zhu, D., Zhao, X., Chen, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00941 · Cited by 66
“For example, in a skin tumor model, the overexpression of NF-κB inhibits invasive epidermal tumors (Dajee et al., 2003).”
BackgroundZhou, X., Chen, X., Hu, L., Han, S., Qiang, F., Wu, Y., Li, P., Shen, H., Li, Y., & Hu, Z. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.020 · Cited by 65
“Laminin-5 is also required for RAS and NF-kappaB blockade induced tumorigenesis of human squamous cell carcinoma [12,13], and serves as a transient receptor to aid HPV infection and expansion [14].”
BackgroundMassoumi, R., & Paus, R. (2007) · BioEssays · doi:10.1002/bies.20677 · Cited by 65
Yang, L., Zhang, L., Wu, Q., & Boyd, D. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806965200 · Cited by 60
Targets for molecular therapy of skin cancer
Green, C. L., & Khavari, P. A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.11.007 · Cited by 64
Self-citationCorticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes
Zbytek, B., Pfeffer, L., & Slominski, A. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.181r001 · Cited by 63
β4 Integrin and Laminin 5 Are Aberrantly Expressed in Polycystic Kidney Disease
Joly, D. A., Morel, V., Hummel, A., Ruello, A., Nusbaum, P., Patey, N., Noël, L., Rousselle, P., & Knebelmann, B. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63539-0 · Cited by 64
Waterman, E. A., Sakai, N., Nguyen, N. T., Horst, B. A. J., Veitch, D. P., Dey, C. N., Ortiz-Urda, S., Khavari, P. A., & Marinkovich, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4141 · Cited by 62
“This model has been used to show, through both antibody inhibition and genetic deletion/restoration studies, that laminin332 and collagen VII are each required for SCC tumorigenesis (7, 8).”
BackgroundMethodSelf-citationDu, F., Nakamura, Y., Tan, T.-L., Lee, P., Lee, R., Yu, B., & Jamora, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0324 · Cited by 65
Metadata
- Authors
- Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., & Khavari, P. A.
- Affiliations
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- ORCID
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6923
- Pages
- 639-643
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986301169
- Cited by
- 535
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 20 · 2015: 21 · 2014: 22 · 2013: 25 · 2012: 23
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, oncogenic Ras, IκBα, cell cycle arrest, laminin-5, alpha6beta4 integrin, carcinogenesis, skin cancer
- MeSH terms
- NF-KappaB Inhibitor alpha, Kalinin, Animals, Cell Division, Epidermis, Humans, Mice, Nude, Neoplasm Invasiveness, Neoplasms, Genes, ras, Transduction, Genetic, Keratinocytes, Oncogene Protein p21(ras), Cell Adhesion Molecules, NF-kappa B, Mice, SCID, Telomere, Apoptosis, Cyclin-Dependent Kinases, I-kappa B Proteins, Integrin alpha6beta4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.